Drotrecogin Alfa (Activated) for Nonmenstrual Toxic Shock Syndrome Associated With Methicillin Resistant Staphylococcus Aureus Infection
Document Type
Article
Publication Date
11-1-2006
Description
Nonmenstrual toxic shock syndrome (TSS) due to Staphylococcus aureus can lead to significant morbidity and mortality. While drotrecogin alfa (DA) has been employed in patients with Methicillin-resistant Staphylococcus aureus (MRSA) severe sepsis and septic shock, its utility in TSS remains unclear. The authors report a case of severe sepsis in the setting of MRSA-associated TSS that responded to treatment with DA. This case illustrates a potential role for DA in the treatment of toxic shock syndromes and emphasizes the importance of aggressive diagnostic and therapeutic modalities in approaching these conditions.
Citation Information
Haddadin, Dafer; Samnani, Imran Q.; and Moorman, Jonathan P.. 2006. Drotrecogin Alfa (Activated) for Nonmenstrual Toxic Shock Syndrome Associated With Methicillin Resistant Staphylococcus Aureus Infection. Southern Medical Journal. Vol.99(11). 1295-1296. https://doi.org/10.1097/01.smj.0000234646.27647.a6 PMID: 17195430 ISSN: 0038-4348